Who has invested in i2o Therapeutics?

Sanofi Ventures, JDRF T1D Fund, Colorcon Ventures are named among the investors backing i2o Therapeutics.

i2o Therapeutics Funding: $46M Raised, Series A (2023)

i2o Therapeutics funding overview

i2o Therapeutics is based in Boston. i2o Therapeutics has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2023. The round record for i2o Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Sanofi Ventures, JDRF T1D Fund, Colorcon Ventures. 3 distinct backers are named across the disclosed rounds.

i2o Therapeutics at a glance

Total raised: $46M
Latest round: Series A
Latest round date: August 2023
Headquarters: Boston
Notable investors: Sanofi Ventures, JDRF T1D Fund, Colorcon Ventures

Frequently asked about i2o Therapeutics funding

How much has i2o Therapeutics raised?: i2o Therapeutics has raised $46M in total disclosed funding across the rounds on record.
Who has invested in i2o Therapeutics?: Sanofi Ventures, JDRF T1D Fund, Colorcon Ventures are named among the investors backing i2o Therapeutics.
What was the latest i2o Therapeutics funding round?: The most recent disclosed round is a Series A, announced in August 2023.
Where is i2o Therapeutics based?: i2o Therapeutics is based in Boston.
When did i2o Therapeutics last raise?: The last disclosed i2o Therapeutics round closed in August 2023 at Series A.

Round data for i2o Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

i2o Therapeutics Funding: $46M Raised, Series A (2023)

i2o Therapeutics funding overview

i2o Therapeutics at a glance

Frequently asked about i2o Therapeutics funding

Companies related to i2o Therapeutics (36)

Browse related funding lists (6)